Journal
ACTA CYTOLOGICA
Volume 49, Issue 5, Pages 471-476Publisher
KARGER
DOI: 10.1159/000326190
Keywords
in situ hybridization; fluorescence; aspiration biopsy; fine-needle; breast cancer; gene amplification; HER-2/neu
Categories
Ask authors/readers for more resources
Objective: To assess the usefulness of fluorescence in situ hybridization (FISH) for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy (FNAB) specimens. Study Design: All FISH performed on formalin-fixed, paraffin-embedded surgical specimens during Janurary 2003-August 2003 at the University of California, Irvine Medical Center were selected. Prior FNABs were retrieved. One cytologic slide was destained in each case. The results were compared with those obtained on histologic paired t test. Results: FISH was performed on 41 surgical specimens of breast carcinoma. Thirteen patients had prior FNABs that were positive for adenocarcinoma. After hybridization on destained fine needle aspiration slides, no cells were found in 2 cases, and. the results were not readable in 2 cases. In the remaining 9 cases, the results, expressed as the ratio of copies of the HER-2/neu gene to copies of the chromosome 17 centromere, were 5.10, 1.14, 1.21, 1.12, 0.74, 1.11, 1.21, 9.87 and 2.4. Results on the corresponding histologic specimens were 5.25, 1.05, 1.13, 1.22, 1.13, 1.12, 1.21, 9.35 and 2.61, respectively. No significant difference was found (p = 0. 23). Conclusion: HER-2/neu amplifications status by FISH can be accurately and reliably evaluated in existing archival cytologic slides.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available